NVO logo

Novo Nordisk A/S (NVO) Long term liabilities

Annual long term liabilities:

$2.10B-$531.36M(-20.21%)
December 31, 2024

Summary

  • As of today (September 13, 2025), NVO annual total long term liabilities is $2.10 billion, with the most recent change of -$531.36 million (-20.21%) on December 31, 2024.
  • During the last 3 years, NVO annual long term liabilities has risen by +$372.26 million (+21.57%).
  • NVO annual long term liabilities is now -20.21% below its all-time high of $2.63 billion, reached on December 31, 2023.

Performance

NVO Long term liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVObalance sheet metrics

quarterly long term liabilities:

$3.03B+$395.90M(+15.03%)
June 1, 2025

Summary

  • As of today (September 13, 2025), NVO quarterly total long term liabilities is $3.03 billion, with the most recent change of +$395.90 million (+15.03%) on June 1, 2025.
  • Over the past year, NVO quarterly long term liabilities has increased by +$537.70 million (+21.57%).
  • NVO quarterly long term liabilities is now at all-time high.

Performance

NVO quarterly long term liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVObalance sheet metrics

Long term liabilities Formula

Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities

NVO Long term liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-20.2%+21.6%
3 y3 years+21.6%+102.5%
5 y5 years+131.7%+232.5%

NVO Long term liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-20.2%+21.6%at high+102.5%
5 y5-year-20.2%+131.7%at high+232.5%
alltimeall time-20.2%+3821.0%at high+5012.4%

NVO Long term liabilities History

DateAnnualQuarterly
Jun 2025
-
$3.03B(+15.0%)
Mar 2025
-
$2.63B(+25.6%)
Dec 2024
$2.10B(-20.2%)
$2.10B(-18.1%)
Sep 2024
-
$2.56B(+2.8%)
Jun 2024
-
$2.49B(-2.4%)
Mar 2024
-
$2.55B(-2.9%)
Dec 2023
$2.63B(+46.4%)
$2.63B(+26.5%)
Sep 2023
-
$2.08B(-0.5%)
Jun 2023
-
$2.09B(+2.8%)
Mar 2023
-
$2.03B(+13.1%)
Dec 2022
$1.80B(+4.1%)
$1.80B(+15.9%)
Sep 2022
-
$1.55B(+3.6%)
Jun 2022
-
$1.50B(-8.2%)
Mar 2022
-
$1.63B(-5.5%)
Dec 2021
$1.73B(+24.6%)
$1.73B(+52.8%)
Sep 2021
-
$1.13B(-2.7%)
Jun 2021
-
$1.16B(-4.3%)
Mar 2021
-
$1.21B(-12.4%)
Dec 2020
$1.39B(+53.0%)
$1.39B(+29.5%)
Sep 2020
-
$1.07B(+17.4%)
Jun 2020
-
$911.40M(+6.8%)
Mar 2020
-
$853.43M(-5.7%)
Dec 2019
$905.36M(+24.0%)
$905.36M(+4.4%)
Sep 2019
-
$867.48M(+8.3%)
Jun 2019
-
$801.34M(+9.8%)
Mar 2019
-
$729.77M(-0.0%)
Dec 2018
$730.09M(-17.5%)
$730.09M(-5.5%)
Sep 2018
-
$772.23M(-1.2%)
Jun 2018
-
$781.63M(-8.0%)
Mar 2018
-
$850.04M(-3.9%)
Dec 2017
$884.46M(+29.0%)
$884.46M(-4.3%)
Sep 2017
-
$924.25M(+8.3%)
Jun 2017
-
$853.68M(+18.5%)
Mar 2017
-
$720.43M(+5.1%)
Dec 2016
$685.72M(+19.0%)
$685.72M(+2.8%)
Sep 2016
-
$667.23M(+7.5%)
Jun 2016
-
$620.59M(+1.2%)
Mar 2016
-
$613.34M(+6.5%)
Dec 2015
$576.00M(+15.1%)
$576.00M(+8.0%)
Sep 2015
-
$533.12M(-1.1%)
Jun 2015
-
$539.03M(+11.6%)
Mar 2015
-
$483.04M(-3.5%)
Dec 2014
$500.35M(-23.5%)
$500.35M(-10.2%)
Sep 2014
-
$557.47M(-7.2%)
Jun 2014
-
$600.90M(-0.2%)
Mar 2014
-
$601.99M(-8.0%)
Dec 2013
$654.40M(+9.0%)
$654.40M(+7.6%)
Sep 2013
-
$608.02M(-0.7%)
Jun 2013
-
$612.04M(+17.7%)
Mar 2013
-
$520.20M(-13.4%)
Dec 2012
$600.63M(-42.4%)
$600.63M(-17.7%)
Sep 2012
-
$730.16M(-19.1%)
Jun 2012
-
$902.84M(-20.5%)
Mar 2012
-
$1.14B(+9.0%)
Dec 2011
$1.04B
$1.04B(+0.9%)
DateAnnualQuarterly
Sep 2011
-
$1.03B(-2.7%)
Jun 2011
-
$1.06B(+1.8%)
Mar 2011
-
$1.04B(+6.1%)
Dec 2010
$982.38M(+60.8%)
$982.38M(+7.8%)
Sep 2010
-
$911.21M(+34.9%)
Jun 2010
-
$675.34M(-21.8%)
Mar 2010
-
$863.52M(+8.2%)
Dec 2009
$610.85M(+64.4%)
$797.88M(+19.8%)
Sep 2009
-
$665.99M(+10.6%)
Jun 2009
-
$601.97M(+7.3%)
Mar 2009
-
$560.98M(+1.1%)
Dec 2008
$371.64M(+33.0%)
$554.66M(+8.0%)
Sep 2008
-
$513.39M(+1.3%)
Jun 2008
-
$506.82M(+7.9%)
Mar 2008
-
$469.80M(+0.4%)
Dec 2007
$279.41M(+18.9%)
$467.84M(-7.4%)
Sep 2007
-
$505.02M(+22.9%)
Jun 2007
-
$410.87M(-6.3%)
Mar 2007
-
$438.58M(-0.9%)
Dec 2006
$234.92M(-8.2%)
$442.59M(-2.9%)
Sep 2006
-
$455.76M(-3.1%)
Jun 2006
-
$470.54M(+0.1%)
Mar 2006
-
$469.95M(+3.7%)
Dec 2005
$255.87M(-17.2%)
$453.23M(-15.6%)
Sep 2005
-
$536.86M(+40.2%)
Jun 2005
-
$382.92M(-20.0%)
Mar 2005
-
$478.52M(-9.1%)
Dec 2004
$309.18M(+14.3%)
$526.26M(+50.6%)
Sep 2004
-
$349.49M(+1.3%)
Jun 2004
-
$345.05M(-0.6%)
Mar 2004
-
$347.13M(-12.8%)
Dec 2003
$270.53M(+7.9%)
$398.09M(+58.8%)
Dec 2002
$250.76M(-23.2%)
$250.76M(-23.2%)
Dec 2001
$326.71M(+7.8%)
$326.71M(+7.8%)
Dec 2000
$303.03M(-0.8%)
$303.03M(-0.8%)
Dec 1999
$305.33M(-49.0%)
$305.33M(-49.0%)
Dec 1998
$598.57M(+85.7%)
$598.57M(+85.7%)
Dec 1997
$322.29M(+41.8%)
$322.29M(+41.8%)
Dec 1996
$227.23M(-29.4%)
$227.23M(-29.4%)
Dec 1995
$322.08M(-42.7%)
$322.08M(-42.7%)
Dec 1994
$561.81M(+5.8%)
$561.81M(+5.8%)
Dec 1993
$530.95M(+18.8%)
$530.95M(+18.8%)
Dec 1992
$447.01M(+38.1%)
$447.01M(+38.1%)
Dec 1991
$323.71M(+43.6%)
$323.71M(+43.6%)
Dec 1990
$225.37M(-15.0%)
$225.37M(-15.0%)
Dec 1989
$265.19M(+87.6%)
$265.19M(+87.6%)
Dec 1988
$141.34M(-12.3%)
$141.34M(-12.3%)
Dec 1987
$161.14M(-37.0%)
$161.14M(-37.0%)
Dec 1986
$255.73M(+171.9%)
$255.73M(+171.9%)
Dec 1985
$94.04M(+58.7%)
$94.04M(+58.7%)
Dec 1984
$59.27M(+10.8%)
$59.27M
Dec 1983
$53.50M(-8.8%)
-
Dec 1982
$58.64M(-15.5%)
-
Dec 1981
$69.41M(-6.9%)
-
Dec 1980
$74.58M
-

FAQ

  • What is Novo Nordisk A/S annual total long term liabilities?
  • What is the all time high annual long term liabilities for Novo Nordisk A/S?
  • What is Novo Nordisk A/S annual long term liabilities year-on-year change?
  • What is Novo Nordisk A/S quarterly total long term liabilities?
  • What is the all time high quarterly long term liabilities for Novo Nordisk A/S?
  • What is Novo Nordisk A/S quarterly long term liabilities year-on-year change?

What is Novo Nordisk A/S annual total long term liabilities?

The current annual long term liabilities of NVO is $2.10B

What is the all time high annual long term liabilities for Novo Nordisk A/S?

Novo Nordisk A/S all-time high annual total long term liabilities is $2.63B

What is Novo Nordisk A/S annual long term liabilities year-on-year change?

Over the past year, NVO annual total long term liabilities has changed by -$531.36M (-20.21%)

What is Novo Nordisk A/S quarterly total long term liabilities?

The current quarterly long term liabilities of NVO is $3.03B

What is the all time high quarterly long term liabilities for Novo Nordisk A/S?

Novo Nordisk A/S all-time high quarterly total long term liabilities is $3.03B

What is Novo Nordisk A/S quarterly long term liabilities year-on-year change?

Over the past year, NVO quarterly total long term liabilities has changed by +$537.70M (+21.57%)
On this page